Abstract:Chronic liver disease is a major cause of morbidity and mortality worldwide. Epidemiology, clinical phenotype and response to therapies for gastrointestinal and liver diseases are commonly different between women and men due to sex-specific hormonal, genetic and immune-related factors. The hepatic immune system has unique regulatory functions that promote the induction of intrahepatic tolerance, which is key for maintaining liver health and homeostasis. In liver diseases, hepatic immune alterations are increasingly recognized as a main cofactor responsible for the development and progression of chronic liver injury and fibrosis. In this Review, we discuss the basic mechanisms of sex disparity in hepatic immune regulation and how these mechanisms influence and modify the development of autoimmune liver diseases, genetic liver diseases, portal hypertension and inflammation in chronic liver disease. Alterations in gut microbiota and their crosstalk with the hepatic immune system might affect the progression of liver disease in a sex-specific manner, creating potential opportunities for novel diagnostic and therapeutic approaches to be evaluated in clinical trials. Finally, we identify and propose areas for future basic, translational and clinical research that will advance our understanding of sex disparities in hepatic immunity and liver disease.

Author Correction: Hepatic immune regulation and sex disparities

Hepatic immune regulation and sex disparities

Author Correction: BHMT Polymorphism and Susceptibility to PTE in Chinese Patients.

Corrigendum: Immune Tolerance Induced by Hematopoietic Stem Cell Infusion after HLA Identical Sibling Kidney Transplantation

Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Author Correction: Prevalence and Characteristics of Hypoxic Hepatitis in the Largest Single-Centre Cohort of Avian Influenza A(H7N9) Virus-Infected Patients with Severe Liver Impairment in the Intensive Care Unit

Corrigendum to “artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis”

Corrigendum: Sex differences in the genetics of sarcoidosis across European and African ancestry populations

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Corrigendum to “sex Differences in HIV Treatment Outcomes and Adherence by Exposure Groups among Adults in Guangdong, China: A Retrospective Observational Cohort Study” [eclinicalmedicine 22 (2020) 100351]

Correction: Corrigendum: Increased Duodenal Eosinophil Degranulation in Patients with Functional Dyspepsia: A Prospective Study

Author Correction to ‘FGF4 Protects the Liver from Immune-Mediated Injury by Activating CaMKKβ-PINK1 Signal Pathway to Inhibit Hepatocellular Apoptosis’ [acta Pharmaceutica Sinica B 14(2024)1605-1623]

Correction to: Tackling cardiovascular healthcare disparities for the LGBTQIA+ population: a call to action

Corrigendum: Blood Immune Cell Composition Associated With Obesity and Drug Repositioning Revealed by Epigenetic and Transcriptomic Conjoint Analysis

Erratum: Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy [Corrigendum]

Corrigendum: Germline-Encoded TCR-MHC Contacts Promote TCR V Gene Bias in Umbilical Cord Blood T Cell Repertoire

Correction: De Sanctis et al. Lck Function and Modulation: Immune Cytotoxic Response and Tumor Treatment More Than a Simple Event. Cancers 2024, 16, 2630

Author Correction: Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis

Correction to "Influence of donor-recipient sex on engraftment of normal and leukemia stem cells in xenotransplantation"

Corrigendum to “Seminal plasma metabolomics signatures of normosmic congenital hypogonadotropic hypogonadism” [Heliyon 9(4) (March 2023) e14779]

Author Correction: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women